
Journal of labelled compounds and radiopharmaceuticals p. 425 - 433 (1996)
Update date:2022-08-02
Topics:
Gong, Leyi
Pames, Howard
The preparation of the title compound, a selective 5-HT3 antagonist with anti-emetic properties, is described. The key intermediate involved is 6-bromo-1,2-dihydronaphthoid acid (5), which was synthesized from 4-bromophenylacetic acid by Micheal addition, acid-induced ring cyclization, reduction and dehydration. Compound (5) was selected because it has two labelling sites to ensure high specific activity of the final product. Reduction of amide 6 with carrier-free tritium gas, followed by reduction of the amide functional group with BF3-OEt2 and intramolecular cyclization furnished the title compound having a specific activity of 70.4 Ci/mmol and >99% purity.
View MoreShangHai Ruiyi Medical Technology Co.,Ltd.
Contact:+86-21-54718086
Address:No951 Jianchuan RD,Minhang District
Contact:+86-158-5814-5714
Address:No.9 YanAn Road,Hangzhou,Zhejiang,China
Daicel Chiral Technologies (China)CO.,LTD
Contact:021-5046-0086*8
Address:Part C, FL 5, the 16th Building, No. 69, XiYa Road, WaiGaoQiao Free Trade Zone, Shanghai, 200131, P.R.China
Yixing Bluwat Chemicals Co., Ltd.
Contact:+86 510 87821568
Address:Yongan Road, Yixing Chemical Industrial Park, Yixing, Jiangsu, China
shandong zhongke taidou chemical co.,ltd
Contact:86-531-88682301
Address:Jinan shandong Province CHina
Doi:10.1021/acs.jmedchem.9b01649
(2019)Doi:10.1016/j.bmcl.2010.08.043
(2010)Doi:10.1002/hlca.19960790321
(1996)Doi:10.1016/j.jorganchem.2007.11.023
(2008)Doi:10.1021/acsmedchemlett.5b00102
(2015)Doi:10.1016/0040-4020(96)00258-X
(1996)